ALPANA Ventures

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

eMonitor GmbH specializes in property management software tailored for apartment managers, municipalities, and social housing cooperatives. Founded in 2014 and headquartered in Zurich, Switzerland, the company has developed MiMo, a comprehensive B2B platform that digitizes the rental process from initial tenant contact to the signing of rental contracts. This software facilitates the matching of apartments with prospective tenants while optimizing for various factors such as social, environmental, and financial benefits. It streamlines application management, automates credit checks and tenant selection, and supports communication with future tenants. Additionally, eMonitor's platform includes data analysis tools to track the rental process and tenant demographics, allowing property owners to efficiently manage apartment allocations and enhance tenant satisfaction.

Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Tinamu is a spin-off from the Swiss Federal Institute of Technology in Zurich that specializes in robotics and automation. The company has developed an advanced drone-based platform that enables autonomous indoor inspections and stockpile volume monitoring within warehouses. Operating primarily in Europe, Tinamu serves clients across several industries, including metals, mining, minerals, construction, and biomass. Its technology integrates a drone system, a secured cloud analytics software, and a user-friendly dashboard, allowing businesses to acquire precise data on their assets and gain insightful analytics tailored to their needs. This innovative approach enhances operational efficiency and data accuracy for its customers.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

eMonitor GmbH specializes in property management software tailored for apartment managers, municipalities, and social housing cooperatives. Founded in 2014 and headquartered in Zurich, Switzerland, the company has developed MiMo, a comprehensive B2B platform that digitizes the rental process from initial tenant contact to the signing of rental contracts. This software facilitates the matching of apartments with prospective tenants while optimizing for various factors such as social, environmental, and financial benefits. It streamlines application management, automates credit checks and tenant selection, and supports communication with future tenants. Additionally, eMonitor's platform includes data analysis tools to track the rental process and tenant demographics, allowing property owners to efficiently manage apartment allocations and enhance tenant satisfaction.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

Artmyn SA specializes in the digitization of visual artworks, offering a comprehensive platform that allows users to access high-quality digital representations of art through web browsers on various devices, including laptops, smartphones, and tablets. Founded in 2015 and based in Belmont-sur-Lausanne, Switzerland, the company utilizes a portable scanner to capture extensive data about artworks, ensuring accurate and detailed visualizations. Artmyn provides an array of services such as online galleries, interactive guided tours, educational resources, and conservation monitoring tools, catering to museums, galleries, auction houses, and both private and institutional collectors. By enhancing the art viewing experience, Artmyn facilitates greater transparency and engagement for art buyers and enthusiasts alike.

Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Saphetor SA, founded in 2014 and based in Lausanne, Switzerland, specializes in data-driven solutions aimed at enhancing diagnostics and therapy selection for cancer and challenging medical conditions, including rare diseases and cognitive impairments. The company's flagship platform, VarSome, serves as a comprehensive resource for human genome data, offering extensive variant analyses that assist healthcare professionals in accurately identifying genetic causes of diseases. By facilitating the selection of targeted therapies, stratifying patients for clinical trials, and supporting drug development through sub-population analysis, Saphetor plays a critical role in modern precision medicine. Its technology also aids in the discovery and validation of new drug targets and biomarkers, significantly improving patient outcomes and healthcare practices globally.